ATP7A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.08322248340664E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.15303338993544E-14 |
Normal-vs-Stage2 |
3.17300000052256E-07 |
Normal-vs-Stage3 |
6.18990000367248E-08 |
Normal-vs-Stage4 |
6.179000E-03 |
Stage1-vs-Stage2 |
6.031400E-01 |
Stage1-vs-Stage3 |
2.907400E-01 |
Stage1-vs-Stage4 |
7.465000E-01 |
Stage2-vs-Stage3 |
7.411000E-01 |
Stage2-vs-Stage4 |
9.653400E-01 |
Stage3-vs-Stage4 |
7.666400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.74638081773537E-13 |
Normal-vs-AfricanAmerican |
1.34160460518729E-11 |
Normal-vs-Asian |
1.580850E-03 |
Caucasian-vs-AfricanAmerican |
9.166800E-01 |
Caucasian-vs-Asian |
5.320800E-01 |
AfricanAmerican-vs-Asian |
5.527200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
2.3566000000308E-06 |
Male-vs-Female |
2.363400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.63239999295683E-09 |
Normal-vs-Extreme_Weight |
1.63136171238421E-12 |
Normal-vs-Obese |
9.00279961690842E-10 |
Normal-vs-Extreme_Obese |
2.97350000177943E-09 |
Normal_Weight-vs-Extreme_Weight |
3.807400E-01 |
Normal_Weight-vs-Obese |
4.134400E-01 |
Normal_Weight-vs-Extreme_Obese |
2.228000E-01 |
Extreme_Weight-vs-Obese |
4.362100E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.616600E-01 |
Obese-vs-Extreme_Obese |
2.637800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.150500E-04 |
Normal-vs-Age(41-60Yrs) |
6.48540110503859E-11 |
Normal-vs-Age(61-80Yrs) |
4.10782519111308E-15 |
Normal-vs-Age(81-100Yrs) |
1.48720036285965E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.874000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.307500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.554100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.319800E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.022300E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.427200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
Normal-VS-Type2 PRCC |
9.31688060035185E-12 |
Normal-VS-KIRP CIMP |
6.169900E-02 |
Normal-VS-Unclassified PRCC |
1.552080E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.602600E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.010800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.289800E-02 |
Type2 PRCC-VS-KIRP CIMP |
2.233600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.845600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.944000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.91176021866613E-13 |
Normal-vs-N1 |
3.93790000000616E-05 |
Normal-vs-N2 |
3.029400E-01 |
N0-vs-N1 |
2.101800E-01 |
N0-vs-N2 |
2.423800E-02 |
N1-vs-N2 |
2.283800E-01 |
|
|